. 2015 Nov 13;15:180. doi: 10.1186/s12887-015-0487-4

Table 1.

The Norwegian Vaccination Programme during 2010–2012, aged < 2 years

Age (months)	Target disease	Vaccine	Number of injections
3	Diphtheria, tetanus, pertussis, polio, Haemophilus influenza type b	Infanrix-Polio + Hib® (GSK), Prevenar®^a (Pfizer)	2
3	Invasive pneumococcal disease	Infanrix-Polio + Hib® (GSK), Prevenar®^a (Pfizer)	2
5	Diphtheria, tetanus, pertussis, polio, Haemophilus influenza type b	Infanrix-Polio + Hib® (GSK), Prevenar®^a (Pfizer)	2
5	Invasive pneumococcal disease	Infanrix-Polio + Hib® (GSK), Prevenar®^a (Pfizer)	2
12	Diphtheria, tetanus, pertussis, polio, Haemophilus influenza type b	Infanrix-Polio + Hib® (GSK) Prevenar®^a (Pfizer)	2
12	Invasive pneumococcal disease	Infanrix-Polio + Hib® (GSK) Prevenar®^a (Pfizer)	2
15	Measles,mumps,rubella	M-M-RVaxpro® (Sanofi Pasteur MSD)	1
From early age	Hepatitis B^b	Engerix-B® (GSK)	varies
From early age	Tuberculosis^b	BCG-SSI®	1

^aChange from Prevenar 7 to Prevenar 13, April 2011; ^bRisk groups